TipRanks
Go Ultimate55% OFF

EyePoint Pharmaceuticals (EYPT) Balance Sheet

EyePoint Pharmaceuticals Balance Sheet

EyePoint Pharmaceuticals's total assets for Q2 2026 were $228.19M, a decrease of 20.83% from the previous quarter. EYPT total liabilities were $61.78M for the fiscal quarter, a 6.99% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 364.00M$ 418.46M$ 355.18M$ 180.36M$ 263.37M
$ 57.88M$ 81.96M$ 88.86M$ 83.99M$ 78.99M
$ 306.11M$ 336.50M$ 266.32M$ 96.37M$ 184.38M

Currency in USD

EyePoint Pharmaceuticals Debt to Assets

0150M300M450M0 %40 %80 %120 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets